Trinity Biotech diabetes product approved by FDA

Bray based Trinity Biotech has announced that it has obtained FDA approval for its diabetes diagnosis system, Premier Hb9210.

6th December, 2011

Bray based Trinity Biotech has announced that it has obtained FDA approval for its diabetes diagnosis system, Premier Hb9210.

The Premier instrument measures HbA1c ora patient's average blood sugar control over the last two to three months and is a key tool in the diagnosis and monitoring of diabetes, the company said in a statement.

FDA approval enables the instrument to be launched and sold in the United States and will greatly facilitate sales...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago